Clinical trial
Mechanistic and Prognostic Evaluation of Central Venous Catheter-Associated Right Atrial Thrombus
NCT07549477 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mechanistic and Prognostic Evaluation of Central Venous Catheter-Associated Right Atrial Thrombus
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 15, 2026
- Completion date
- April 30, 2029
- Enrollment
- 150 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
adult cancer patients, right atrial clot